Skip to main content
Clinical Trials/ISRCTN67560441
ISRCTN67560441
Completed
未知

Electronic data capture of Health Related Quality of Life Patient Reported Outcome Measures (PROMS). An exploratory study in Patients with Prostate Cancer.

Brighton and Sussex University Hospitals NHS Trust0 sites40 target enrollmentDecember 5, 2016

Overview

Phase
未知
Intervention
Not specified
Conditions
Specialty: Cancer, Primary sub-specialty: Prostate Cancer
Sponsor
Brighton and Sussex University Hospitals NHS Trust
Enrollment
40
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 5, 2016
End Date
July 31, 2017
Last Updated
6 years ago
Study Type
Observational
Sex
Male

Investigators

Sponsor
Brighton and Sussex University Hospitals NHS Trust

Eligibility Criteria

Inclusion Criteria

  • 1\. Adult patients \> 18 years
  • 2\. Diagnosis of prostate cancer not suitable for radical (curative) treatment
  • 3\. Commencing palliative systemic therapy (first or subsequent lines) – cytotoxic chemotherapy, modern hormonal agents (including enzalutamide and abiraterone) and radium 223\.

Exclusion Criteria

  • 1\. Already commenced treatment
  • 2\. Treated with androgen deprivation therapy, stilboestrol or dexamethasone only.
  • 3\. Treated with trial treatments that are not NICE or Cancer Drug Fund approved

Outcomes

Primary Outcomes

Not specified

Similar Trials